Pharmalot By Ed Silverman Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
First Opinion By Els Torreele Global health should not be determined by pharma investors and shareholders
Health By Helen Branswell Experts fear U.S. may default to annual Covid boosters without sufficient data
Special Report By STAT Staff Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
Health By Lauran Neergaard — Associated Press FDA clears Covid booster shot for healthy kids ages 5 to 11
Pharmalot By Ed Silverman National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
Politics By Lev Facher Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?
Pharmalot By Ed Silverman A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
Pharmalot By Ed Silverman U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines
Pharmalot By Ed Silverman Pharmalittle: Investors reject proposals for Covid vaccine makers to share know-how; CMS head says Alzheimer’s drug decision is rare
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum
Health By Lauran Neergaard — Associated Press Moderna seeks to be first with Covid shots for children younger than 6
Pharmalot By Ed Silverman Pharmalittle: Amgen faces $7B IRS back-tax bill and fine; McKinsey exec apologizes for opioid work during hearing
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices
First Opinion By Dawn Sinclair Shapiro Men and women may respond differently to vaccines. Research needs to account for that
Health By Helen Branswell Kizzmekia Corbett on the pandemic, public service, and her path to becoming a scientist
First Opinion By Dinesh Thakur India’s drug regulator has ignored red alerts on Covaxin, imperiling millions of lives
Health By Lauran Neergaard — Associated Press Pfizer to seek Covid booster for healthy 5- to 11-year-olds
First Opinion By Christopher M. Worsham and Anupam B. Jena The ‘successful failures’ of Apollo 13 and Covid-19 vaccination
The Readout LOUD By Adam Feuerstein and Meg Tirrell Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success
Health By Andrew Joseph and Matthew Herper Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters
First Opinion By Rebecca Weintraub, Benjy Renton and David C. Grabowski Narrowing the vaccine gap as boosters begin for people over 50
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO
First Opinion By John P. Moore and Luciana L. Borio Covid-19 vaccine policy should be made by public health experts, not company executives